- Registration Closed
This lecture will cover the spectrum of disorders that cause hair loss and overgrowth. The most common conditions that cause scarring and nonscarring alopecia will be discussed in detail, as well as hirsutism. Susan Mayne will walk you through assessment, diagnosis, and the most current treatment options available to you and your adult and pediatric patients.
Credits: 1.00 contact hours; 0.50 are pharmacology
Release Date: October 15, 2021
$25
Learning Objectives
After taking part in this educational activity, participants should be better able to:
- Describe the pathophysiology and epidemiology as it relates to the accurate assessment and diagnosis of hair disorders.
- Recognize underlying systemic diseases that may be associated with hair disorders.
- Discuss treatment options, including the pharmacodynamics of medications key in the management of hair conditions.
Susan Mayne, DNP, FNP-C, DCNP
Family Nurse Practitioner
University Hospitals Cleveland Medical Center
Susan Mayne is a Family Nurse Practitioner who practices dermatology at University Hospitals Cleveland Medical Centers (UHCMC) in Cleveland, Ohio. Susan is one of very few in the nation to complete a 2-year interdisciplinary post master’s dermatology NP training program at UHCMC. She is a Clinical Instructor at Case Western School of Medicine and co-founder of the Center for Advanced Practice Dermatology, established to provide dermatology education for NPs. Her clinical focus is complex skin conditions in both pediatric and adult patients. The subject of her DNP research was post-masters, competency-based education for NPs entering the field of dermatology. Her goal is to work with academic leaders and dermatology experts to develop, implement, and evaluate post-maters curriculum and certification preparation for NPs specializing in dermatology.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Susan Mayne, DNP, FNP-C, DCNP, have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.